title: Attention-deficit disorder. A paradigm for psychotropic medication intervention in pediatrics.
abstract: Pediatricians frequently encounter patients with behavioral or academic problems in clinical practice. Assessing and managing these patients requires awareness of the numerous physical, emotional, and psychological causes. Because of their limited contact with these patients during a routine visit, pediatricians as a minimum, should rely on careful parental and social history, teachers' evaluations by checklist, achievement test scores and grades, and the clinicians' own gestalt regarding patients' behavior. This article provides a framework that practitioners can incorporate into their routine office practices. Practitioners must also be knowledgeable about different forms of ADD and learning disabilities, differential diagnosis, and frequently encountered comorbidities. A modest armamentarium of psychotropic drugs potentially useful in the treatment of ADD are available; however, they must be aware of indications, subtle differences in pharmacokinetics, rates of efficacy, and adverse effects for these medications. Appropriate behavioral intervention, educational assessment, and placement when necessary are also essential for optimal management. Enabling the child or adolescent to achieve successfully in school, to experience positive social interactions, and to regain self-esteem are the more rewarding facets of pediatric care.
authors.affiliation: Department of Pediatrics, University of Louisville, Kentucky, USA.
authors.forename: S L
authors.initials: SL
authors.lastname: Block
mesh_terms: D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D008297:Male; D009819:Office Visits; D018579:Patient Selection; D010372:Pediatrics / Q000379:methods*; D011379:Prognosis; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012017:Referral and Consultation
chemical_list: D011619:Psychotropic Drugs